Autumn babies at greater risk of asthma: study

By Julie Steenhuysen

CHICAGO (Reuters) - Babies born four months before the peak cold and flu season have a 30 percent higher risk of developing asthma, U.S. researchers said on Friday, suggesting that these common infections may trigger asthma.

“All infants are exposed to this and it is potentially preventable,” said Dr. Tina Hartert, director of the center for Asthma Research at Vanderbilt University, whose study appears in the American Journal of Respiratory and Critical Care Medicine.

She said it has been known for some time that infants in the Northern Hemisphere born in the fall are at higher risk of developing asthma, but the study is the first to tie this trend to peak viral activity in the winter months.

Hartert and colleagues studied the medical records of 95,000 infants and their mothers in the state of Tennessee.

They found that all babies in the study were at increased risk if they had bronchiolitis, a lung infection usually caused by respiratory syncytial virus or RSV. But autumn babies were at the highest risk.

“What we were able to show was the timing of birth and the risk of developing asthma moves in time almost to the day with the peak of these viral infections each winter,” she said.

While genetic risk factors predispose a child to develop asthma, Hartert thinks environmental exposure such as winter viral infection, and particularly RSV infection, may activate those genes.

Nearly every child is infected with RSV early in life, with infections occurring most often between the ages of 3 and 6 months. The virus usually clears up without serious complications.

Hartert said the task now is to prove that preventing such infections could keep infants from developing asthma. “That is where we are now. We need to prove that preventing this infection prevents this lifelong chronic disease,” she said.

The easiest way to do that would be a vaccine, but so far, none exists. Vaccine makers GenVec Inc, AstraZeneca’s MedImmune unit and others are working on RSV vaccines.

“It’s in the pipeline. We just don’t have one yet,” Hartert said.

(Editing by Will Dunham and Todd Eastham)

Source

--------------------------------------------------------------------------------------------
Related Posts:


WASHINGTON (Reuters) - A usually harmless childhood virus may hide in the lungs and come back to cause wheezing and other symptoms of asthma, U.S. researchers reported on Tuesday. They found evidence that respiratory syncytial virus or RSV stayed in the lungs of mice and caused the overactive airway symptoms that characterize asthma. “This research suggests that

Full Post: “Harmless” virus may hide and cause asthma
--------------------------------------------------------------------------------------------

By Anne Harding NEW YORK (Reuters Health) - Researchers from Johns Hopkins have solved the decades-old mystery of why a vaccine developed to prevent a common childhood viral infection wound up making kids sick. The findings provide important clues to how to develop a safe, effective vaccine against respiratory syncytial virus (RSV), the main cause of wintertime

Full Post: Research shows why 1960s RSV shot sickened children
--------------------------------------------------------------------------------------------

NEW YORK (Reuters Health) - People with asthma are at increased risk of serious infection with pneumococcal bacteria, according to a new analysis of medical records. The findings, along with the high fatality rate from such infections, suggest that adults with asthma would benefit from the pneumococcal vaccine, Dr. Young J. Juhn of the Mayo Clinic

Full Post: Asthma may boost pneumococcal infection risk
--------------------------------------------------------------------------------------------

By Anne Harding NEW YORK (Reuters Health) - The exercise that babies get while suckling at the breast may be an essential component of the respiratory benefits associated with breastfeeding, new research shows. Dr. Ikechukwu U. Ogbuanu of the University of South Carolina in Columbia and colleagues found that by 10 years old children who were breastfed

Full Post: Babies’ nursing workouts build lung capacity
--------------------------------------------------------------------------------------------

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - An experimental malaria vaccine is the most promising yet, protecting up to 65 percent of infants from infection in two studies in Africa, researchers reported on Monday. Separate tests in Kenya and Tanzania showed GlaxoSmithKline’s vaccine called RTS,S could protect babies and toddlers from infection with malaria

Full Post: Glaxo malaria vaccine protects babies, children

Site Navigation

Most Read

Search